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Volume Six: Current Trends, Continuing Issues and New Challenges 
 
Introduction 
 
Susanne MacGregor and Betsy Thom 
 
Re-thinking the policy response 
Volume six presents papers with data on current trends in use of alcohol and drugs and associated 
problems globally.  It looks at current issues regarding use of alcohol and drugs, including of 
substances like synthetic drugs and painkillers, and problems related to ageing.  Current debates on 
drugs and alcohol policy are considered.  As noted in volume one, the trend is towards viewing 
alcohol, tobacco and other drugs (ATOD) together.  
The impact of the link between illicit drugs, crime and violence has led Latin American leaders to 
speak openly about the need for policy change.  Mexico is a country which has been at the forefront 
of concerns about the failures of the war on drugs policy.  Following an attempted crackdown by the 
government, there have been ever-spiralling turf wars over smuggling routes. Some in Latin America 
have argued the problem originates in the United States with its persistent demand for drugs and 
from the flow of guns from the United States to Mexico.  Based on fieldwork in Mexico in 2009 and 
2011, Felbab-Brown 2011 offers some lessons for policy-makers from Mexico’s battle against 
organized crime and drug trafficking.  Building on a series of case studies, the extract included here 
pulls the policy lessons together and provides a set of recommendations for reshaping interdiction 
approaches and improving law enforcement policies in Mexico,  not only to weaken the criminal 
groups but also to reduce the violence, arguably a greater problem than drug trafficking per se. 
Suggestions for policy which she discusses include:-  prioritization of interdiction actions against the 
most violent groups; interdiction operations that target the middle layer of drug trafficking 
organisations;  and establishing a community policing capacity that is accepted by the local 
community. Over time, what is needed in Mexico, she argues, is a deepening of police reform, 
institutionalizing the rule of law, and strengthening socioeconomic development in marginalized 
communities. 
Some of these themes are present in Scenarios for the drug problem in the Americas 2013 – 2025 
(2013) outlined by a group of outstanding, knowledgeable and experienced individuals appointed by 
the Organization of American States (OAS) under a mandate given by the Heads of Government of 
Member States at the 2012 Summit of the Americas in Cartagena de Indias. The leaders of the OAS 
had agreed on the need to analyze the results of the current policy in the Americas, explore new 
approaches and make policy more effective. They emphasised two basic points: that the drug 
problem is one of the most important challenges facing the hemisphere, with its impact on public 
health and the cost incurred by States, especially due to the violence that it brings; and that the 
current approach has not been successful and is not working well enough. A first analytical report 
looked at current trends, best practices, and policy challenges. This was followed by a second report, 
reproduced here. The purpose of constructing these scenarios was to provide a common framework 
and language to support dialogue, debate, and decision-making within and across countries. Four 
possible future responses to the drug problem in the Americas are described –Together, Pathways, 
Resilience, and Disruption. These scenarios are outlined and compared.  
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In Together, the emphasis would shift from controlling drugs to preventing crime, violence, and 
corruption. Like-minded countries would be determined to launch – together – a sustained cam-
paign against transnational criminal organizations and their violence, traffic in drugs, weapons, and 
corrupting influence. Here the single most important goal would be to reduce the violence 
associated with illicit drug trafficking by reducing the power of criminal organizations. 
In Pathways a number of countries would begin experiments that, in effect, lead them to diverge 
from current policies. The result would be different responses, where some countries would pursue 
a path of gradual, evidence-based experimentation and reform, while others maintained current 
legal, regulatory and policy frameworks and focused their energies on demand reduction programs 
through prevention and alternatives to incarceration. Others would push for major changes in high-
consuming countries. Non-problematic use of cannabis would often begin to be seen as a special 
case. The variety of approaches in the pathways scenario reflects a perception that while every 
country experiences the drug problem, they do not do so in the same way, and public opinion varies 
widely. This set of responses argues that countries should be allowed to develop diverse strategies 
to protect their people.  
The Resilience approach would focus on building strong and healthy communities, able to resist the 
attractions of drugs, alcohol and tobacco: there would also be a parallel, pragmatic harm reduction 
response for the significant portion of people incapable of complying with abstinence-based 
treatment objectives and who develop chronic and problematic use. The aim would be a 
comprehensive health and social inclusion set of policies. Resourcing these would however be a key 
challenge.  
Each of these three scenarios has potential but all face obstacles. The fourth scenario Disruption is 
one where, increasingly frustrated by the ineffectiveness of current approaches, some countries 
implement a policy that allows them to opt out of international agreements and disregard the 
production and transit of drugs – particularly cocaine – to focus on issues of most concern to them 
domestically. The Scenarios Report predicts that such a policy would lead to an increase in 
international tensions and conflicts over drugs and organized crime throughout the hemisphere. 
These four scenarios effectively encapsulate the key issues and choices facing science and policy 
today regarding controlled substances.  The articles which follow in volume six look in detail at some 
of these key trends and challenges.  
Although some South American leaders have dared to say that a drug free world is impossible, 
breaking the taboo against questioning the international regime, there is as yet little consensus 
about the direction of policy change. And worldwide, attitudes in some other countries (such as 
Saudi Arabia regarding alcohol and Russia regarding illicit drugs) remain firmly against relaxing 
controls. Public health specialists take heart from what has been achieved in regulating tobacco in 
recent years and see potential in developing shared frameworks to control all psychoactive 
substances. But significant contradictions exist globally between neo- liberal values of mass 
consumption, with the promotion of alcohol and tobacco in emerging economies, and pressures 
towards prohibition on health grounds. Some argue that traditional drugs should be allowed in their 
appropriate cultural context, such as coca leaf and khat, but questions arise around what exactly is a 
traditional drug and what is traditional use, especially in a context of social change and migration (cf 
Odenwald et al 2007; Beckerleg 2010). 
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Latin American leaders point out that the main problem lies with the demand for drugs in the USA. If 
major change is to happen, it will need to begin in America. Already there are signs of a shift with 
reforms at state level with regard to marijuana (cf Cerda et al 2012). The War on Drugs announced 
there by President Nixon in 1971, and influencing international policies ever since, is now in its fifth 
decade and many are questioning whether it has been effective. Criticisms of existing policy are that 
it does not deter and does not rehabilitate. Problems that cannot be ignored include sentencing 
disparities which lead to longer sentences for Black than White offenders. Prison numbers in the US 
have soared to the point where the US now accounts for 25 per cent of the world’s prisoners while 
having only 5 per cent of the world’s population: most of this is driven by drug-related offences. 
However there are signs of change:  for example 17 US states are currently directing money away 
from prison construction toward programmes and services such as treatment and supervision 
designed to reduce the problem of repeat offenders. 
The underlying issue is the endemic and ubiquitous nature of use of psychoactive substances. As 
soon as one is controlled another pops up.  Currently there is growing debate about a perceived 
problem of addiction to prescription opioid medication, a side-effect of the increasing production 
and consumption of pharmaceutical drugs in contemporary societies (cf Conrad 2007).  Many are 
useful medicines, for example in helping with pain relief as part of cancer treatment and for chronic 
pain in an ageing population. But social side-effects are observed:  12 million people in US aged over 
12 years have used prescription opioids non-medically; and celebrities are seen to go in and out of 
treatment programmes, with some notorious deaths bringing attention to the issue. 
 
Global assessments of harm and disease 
Drugs and alcohol are important global issues, with incontrovertible evidence of the burden of 
disease, especially from alcohol, of the link between IDU and HIV/AIDS, and of the harms caused by 
drug trafficking. Five per cent of the global burden of disease is due to alcohol and rates are even 
higher for those under 65 years of age. Rates are higher in Europe and Eastern Europe than in other 
regions of the world but countries with emerging markets, like India and South Korea, are beginning 
to show evidence of alcohol problems (cf Chung et al 2012). Worldwide 16 million people inject 
drugs and East Europe and Central Asia are two key regions where this problem is present (Todd et 
al 2009). With the current economic crisis, especially in the euro zone, there have been cutbacks in 
services and some fear that everything built up over the past thirty years with regard to harm 
reduction may be at risk. 
Globally, new drugs and new patterns of drug use are attracting increasing political, media and 
public attention. The EMCDDA report on The Drug Problem in Europe: New drugs and emerging 
trends 2012 draws on data from the European Union’s early warning system, which was developed 
as a rapid-response mechanism to the emergence of new psychoactive substances. (Other terms 
used loosely in this context are designer drugs and herbal highs). Between 2005 and 2011, 164 new 
psychoactive substances (NPS) were formally notified through the early warning system. In 2011, for 
the third consecutive year, a record number of substances (49) were detected for the first time in 
Europe, up from 41 substances in 2010 and 24 in 2009. Sometimes referred to as legal highs, these 
NPS are substances which have not been scheduled under the 1961 and 1971 United Nations 
international drug control Conventions but may pose a threat to public health (cf Hughes and 
Winstock 2011).  Most new psychoactive substances appearing on the European illicit drugs market 
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are reported to be synthesised outside Europe, with China and, to a lesser extent, India being 
identified as the primary source countries. These may be acquired via the Internet and in smart and 
head shops. Substances involved include ketamine, mephedrone, spice and synthetic cannabinoids. 
They may be marketed with misleading names such as bath salts and often on examination are 
found to contain controlled substances. Drugs acquired over the internet are untested and 
unregulated and deaths have occurred with some people suffering adverse toxic reactions, including 
to substances purchased as diet pills.  
Along with new problems relating to new substances such as NSP/ legal highs- 280 new drugs are 
currently being monitored in the EU - and opioid medication, and new patterns of availability, e.g. 
through internet sales and new trafficking routes (such as West Africa) - are continuing problems 
with familiar substances, with HIV/AIDS and alcohol dependence in Russia (cf McKee 1999; Redmond 
and Spooner 2009), with co-morbidity, ageing substance misusers, and with neglected, marginalized 
and underprivileged groups in general. In China today, a recognized problem is use of amphetamines 
and other stimulants and there are worries about drugs coming into China from Afghanistan and 
links between injecting drug use and HIV/AIDS (cf Macdonald 2007; Chu and Levy 2005). 
Mozambique and Kenya now show evidence of problems of injecting heroin use. In South Africa, 
alcohol and cannabis are the most commonly reported drugs used in treatment populations and 
tobacco use is a major problem (cf Herrick 2012). In Latin America there has been an increase in drug 
use since 1998, although in many countries, like Brazil, alcohol is still the main problem (cf Pantani et 
al 2012). There are hidden populations and street populations. While official policy may argue for 
harm reduction, there can be strong resistance to this in the general population and among staff in 
health agencies. For countries like Mexico, Argentina and Colombia, drug use is primarily a crime 
issue. Legalization has been debated in Guatemala, Bolivia and Uruguay and in the latter country, a 
major policy shift has occurred regarding legalization of marijuana production.  
The picture then is of use and misuse of alcohol and drugs that has by no means been effectively 
controlled, takes various forms and is spreading into many countries of the world. There is lively 
debate about options for alternative policies and evidence that some interventions and policies work 
better than others. However there remain huge variations in perceptions and explanations of the 
issue and both continuities and changes in responses - not surprising perhaps given the complexity 
and variety of human activities contained under the umbrella of drug and alcohol studies. 
Understanding how much disability and death a particular disease causes (known as the burden of 
disease) is important. In 1990, a special World Health Organization (WHO) project was launched, the 
Global Burden of Disease Project. In 2002, on the basis of updated information from this ongoing 
project, the WHO estimated that 91 million people were affected by alcohol use disorders and 15 
million by drug use disorders. 
In their article, Degenhardt et al 2008 describe data from the first 17 countries participating in the 
WHO World Mental Health (WMH) Survey Initiative. Countries covered by the survey were 
Colombia, Mexico, United States, Belgium, France, Germany, Italy, Netherlands, Spain, Ukraine, 
Israel, Lebanon, Nigeria, South Africa, Japan, People’s Republic of China, and New Zealand. This 
paper focuses on lifetime use and age of initiation of tobacco, alcohol, cannabis, and cocaine. The 
key finding was that globally, drug use is not distributed evenly and is not simply related to drug 
policy, since countries with stringent user-level illegal drug policies did not have lower levels of use 
than countries with liberal ones.  
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In general, the US had among the highest levels of use of all drugs. Much lower levels were observed 
in lower income countries in Africa and the Middle East, and lower levels of use were reported in the 
Asian locales covered. The use of drugs seems to be a feature of more affluent countries. In the 
Americas, Europe, Japan, and New Zealand, alcohol had been used by the vast majority of survey 
participants, compared to smaller proportions in the Middle East, Africa, and China. 
The US, which has been driving much of the world’s drug research and drug policy agenda, stands 
out with higher levels of use of alcohol, cocaine, and cannabis, despite punitive illegal drug policies, 
as well as (in many US states), a higher minimum legal alcohol drinking age than many comparable 
developed countries.  
Rehm et al 2009 quantify the burden of mortality and disease attributable to alcohol, both globally 
and for ten large countries:  3·8 per cent of all global deaths and 4·6 per cent of global disability-
adjusted life-years are attributable to alcohol. The disease burden is closely related to the average 
volume of alcohol consumption, and, for every unit of exposure, is strongest in poor people and in 
those who are marginalised from society. Even though most adults worldwide abstain from drinking 
alcohol, consumption is common in many parts of the world. The consequences attributable to 
alcohol account for large costs to societies: they are not limited to health-care costs but also include 
costs related to social harm. 
The countries with the highest overall consumption of alcohol are in Eastern Europe around Russia, 
but other areas of Europe also have high overall consumption. There are some difficulties in 
attempts at measurement and comparison, including the fact that more than 25 per cent of global 
consumption is estimated to be unrecorded.  Alcohol is linked to many disease categories, but 
alcohol-use disorders, cancer, cardiovascular disease, liver cirrhosis, and injury are the most 
important disease categories causally affected by alcohol. Global consumption is increasing, 
especially in the most populous countries of India and China. 
 
The article by Wilsnack et al 2009 draws attention to gender- and age-specific alcohol consumption 
from a review of 35 countries from 1997 to 2007.  The article considers whether there are consistent 
differences between how men and women drink. They found that drinking per se and high-volume 
drinking were consistently more prevalent among men than among women and lifetime abstention 
from alcohol was consistently more prevalent among women. Among drinkers, the prevalence of 
high-frequency drinking was consistently greatest in the oldest age group, particularly among men. 
Interesting it appears that aging does not consistently reduce high volume and heavy episodic 
drinking outside Europe and English-speaking countries. 
 
From a review of 18 countries, China, India, the United States, Brazil, Russia, Colombia, Mexico, 
Turkey, the Czech Republic, Hungary, Russia, Australia, the Netherlands, Switzerland, Sweden and 
South Africa and covering four drugs in detail, cannabis, cocaine, heroin, and amphetamine-type 
stimulants,  Reuter and Trautmann 2009 point to the continuing issue of harms, especially drug-
related deaths, HIV/AIDS and crime. While the number of cannabis users may have declined, the 
sudden and substantial rise in cannabis treatment-seeking suggests that consumption and harms 
related to cannabis may have gone up. The main concern of their study, however, is to review the 
global drug trade. They found no evidence that the global drug problem was reduced during the 
UNGASS period from 1998 to 2007. The drug problem generally lessened in rich countries and 
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worsened in a few large developing or transitional countries. A serious epidemic of opiate use 
occurred in the Russian Federation and Central Asia. Profits from the drug trade went mostly to 
traffickers in consuming countries not in source or transit countries. They conclude that 
enforcement of drug prohibitions has caused substantial unintended harms, many of which were 
predictable. 
 
Drugs, alcohol, development and deprivation 
 
While the bulk of research has drawn its data from affluent rich countries, and theories and policies 
have been shaped by this focus, insufficient attention has been paid to what is happening in middle 
income and low income countries. There is a need for scholars and policy makers concerned with 
development to take seriously the issue of drugs and alcohol (cf Keefer and Loayza 2010). Singer 
2008 provides a wide ranging review of the situation in developing countries. This article highlights 
barriers to development emanating from the drug trade including: interpersonal crime and 
community violence; the corruption of public servants and the disintegration of social institutions; 
the emergence of new or enhanced health problems; the lowering of worker productivity; the 
ensnarement of youth in drug distribution and away from productive education or employment; and 
the skewing of economies to drug production and money laundering.  
 
Large sectors of the world’s population suffer from the intertwined plagues of poverty, inequality, 
and health disparities. While the rate of new HIV infections has slowed in some developing nations, 
rates of infection overall are still growing and the number of people living with HIV has continued to 
grow. Influences on these trends and explanations include modernisation, urbanisation and 
migration - the majority of people on the earth now live in cities. Conditions of poverty and 
inequality potentially encourage use of drugs and alcohol, as in the slum areas of cities where rural-
to-urban migrants face poverty, lack of housing, overcrowding, inadequate water and sanitation, 
disease, street violence and youth unemployment.  
Tajikistan has become an important corridor for heroin from Afghanistan intended for European and 
Russian markets (cf Latypov 2011). Products manufactured and distributed internationally by the 
global tobacco and alcohol industries have caused significant health problems in developing nations. 
Cocaine use in developing countries is concentrated in Latin America and the Caribbean, but there 
has been increased use in recent years in western and southern Africa, also spreading to Kenya and 
other parts of Africa. So while trends in use in developed countries are largely stabilising or falling, 
increasing problems are being experienced in developing countries, especially where poverty and 
ready access to drugs of addiction collide. Along with this remains the older problem of inhalation of 
solvents and various commercial aerosols by street children. 
A range of measures have been suggested or attempted in recent years, including: offering drug crop 
farmers alternative livelihoods by providing them with skills and opportunities to engage in other 
economic activities; harm reduction efforts that lower the health risk among those who choose to 
use drugs, avoid demonizing drugs users, and insure their inclusion as full societal members; and 
effectively controlling the legal drug industry, both in terms of promotional efforts and product 
diversion. To this list, Singer adds the critical need for controlling demand by addressing the 
inequitable social and economic conditions that lead to compensatory drug use in the first place and 
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the health benefits that could be derived from prioritizing prevention and treatment over 
interdiction.  
Klein 2011 reports that African policy makers find themselves confronted by a phenomenon of rising 
substance use, particularly in urban areas. Responses are largely driven by imported models 
advocated by drug control agencies and development partners. There are many unintended 
consequences of drug control policies (as outlined in other articles in this collection). However Klein 
points out that the corrosion of governance related to the drug trade hits particularly hard where 
remuneration of law enforcement is low, supervision poor, and the capacity for internal reform is 
limited. He argues that harm reduction should be the overarching policy principle for African drug 
policy. This rests on recognition that drugs play a part in most societies but acceptance that there 
are definite problems associated with certain patterns of use. 
Mohindra et al 2011 describe alcohol consumption in India and note that it is disproportionately 
higher among poorer and socially marginalised groups, notably Scheduled Tribes. This supports a 
common finding of problematic substance use in severely deprived groups like Australian Aborigines, 
First Nation and Native Americans, linking to exclusion and poverty and loss of power and cultural 
autonomy. These features of deprivation and social collapse are found also in ghettoes and urban 
areas in South America, the USA and elsewhere (see volume two and Perlman 2010). 
The article by Johnston and Boyle 2012 focuses on an issue attracting increasing attention - fetal 
alcohol spectrum disorder (FASD). They describe the experiences of northern British Columbian (BC) 
Aboriginal mothers raising adolescents with FASD:  (on the advice of elders they consulted, the term 
Aboriginal is used in the article to refer to those people who may be First Nations as characterized 
within the Constitution of Canada).  Although FASD is not unique to them, it has had a devastating 
impact on many Aboriginal people and their families in BC. Rather than characterising sub-groups as 
pathological or deviant, these researchers use the insights of postcolonial theory to frame their 
analysis. Aboriginal mothers of children with FASD are faced with societal blame for consuming 
alcohol during pregnancy. In explaining the phenomenon of FASD, Johnston and Boyle refer to the 
historical and collective emotional injury Aboriginal peoples have experienced as a result of 
colonialism. This injury manifests itself in various behaviours, including the abuse of alcohol. 
Unhealthy ways of behaving or coping are seen as ways to protect against pain and trauma. They 
note that FASD can be a hidden disability. Not all individuals who have it share the marked physical 
characteristics attributed to FASD.  The authors develop the concept of Mothering from the Margins 
to explain how marginalization contributes to the vulnerability of children and mothers alike. This 
study is a step toward developing nursing interventions that could prove useful for mothers raising 
adolescents with FASD.  
Murphy and Rosenbaum 1998 show that this issue of personal and social trauma is shared among 
excluded groups in both rich and poor countries. Features of extreme social exclusion and 
experience of trauma are part of the lives of many of those with the most severe problems of 
substance misuse. The drug using women described here had had early lives full of brutal 
experiences, including sexual exploitation, often as children. Recognition of this is only now 
becoming clearer but is an underlying problem in many women who come to drugs services. Murphy 
and Rosenbaum focus on the issue of alcohol and drug use and motherhood and the place of state 
intervention in policy and practice. They give particular attention to the impact of stigma. Stigma is a 
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key condition of relationships involving drug or alcohol dependent people but the most stigmatised 
and abhorred are pregnant drug using women. They point out that even in rich countries poverty 
and inequality are increasing and provision for the poor and in need has been cut back in recent 
years and/or is increasingly set about with conditions, including especially conditions placed on 
mothers.  Media images of Black crack smoking mothers in USA played a key role in encouraging 
more hostile attitudes to welfare, a set of policies since exported to other countries. Racism 
exacerbates the situation in America. Living in a violent neighbourhood is a key fact of life in 
American housing projects as it is in parts of Mexico, Kenya or Brazil (cf Gutiérrez and Atienzo 2011).  
Services rarely meet the needs of women. Murphy and Rosenbaum argue for women-sensitive 
services and better recognition of the importance of trauma as a background to problematic drug 
use among both males and females -  but women with children need extra special attention and 
dedicated services.   
 
New issues and perspectives  
Degenhardt and Hall 2006 note that while there are moves to reduce controls on cannabis in some 
countries, at the same time, there has been rising concern about a possible link between cannabis 
consumption and mental illness. They review evidence from six longitudinal studies in five countries 
to show that regular cannabis use predicts an increased risk of a schizophrenia diagnosis or of 
reporting symptoms of psychosis. They conclude that it is most plausible that cannabis use 
precipitates schizophrenia in individuals who are vulnerable because of a personal or family history 
of schizophrenia (cf Arsenault et al 2004; Gage et al 2013). 
Rich et al 2011 continue the theme found in many studies of the unintended consequences of drug 
policy looking at the harms caused to particular groups, in this case African American men in USA. 
Over the past 40 years, the number of people in U.S. prisons has increased by more than 600 per 
cent. An estimated 10 million Americans are incarcerated each year. No other country locks up more 
of its citizens. This has significant impact on the life-chances of Black American men. It is a 
pronounced effect of the War on Drugs and, they say, of America’s failure to treat addiction and 
mental illness as medical conditions, pointing out that more than half of inmates have symptoms of 
a psychiatric disorder.  
However Williams et al 2008 make the point that not all drug users are mentally ill. There is very 
common use of substances as recreational drugs. The context for this is the pharmaceuticalisation of 
everyday life.  They focus on the new issue of cognitive enhancers, taking us back to one of the long-
standing questions in this field about what are legitimate and what are illegitimate uses of any 
substance? They also raise the question whether certain substances fit better with certain societies 
and economies, citing the role of stimulants in fast capitalism.  
 Jayne et al 2012 discuss the important issue of tourism in our increasingly globalised world: tourism 
is important for local economies but also has implications for both tourists and locals. In particular, 
they look at the role of alcohol, drinking and drunkenness as an aspect of tourist behaviour, 
especially in backpacking holidays. Drawing on empirical research undertaken in Australia, they build 
on a key insight from human geography that space and place are not passive backdrops to drinking 
but are active constituents in the practices and experiences bound up with alcohol consumption. 
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Their article offers ‘rich and vivid insights into the emotional and embodied materialities and 
performativities of backpacking’.  
Van Zee 2009 presents an in-depth analysis of the promotion and marketing of OxyContin (Purdue 
Pharma, Stamford, CT), a sustained-release oxycodone preparation.  By 2002, unintentional 
overdose deaths from prescription opioids surpassed those from heroin and cocaine nationwide in 
the USA. Issues identified here regarding marketed prescriptions include the need to check that drug 
promotion is truthful, balanced, and accurately communicated.  One lesson that could be drawn 
from this study by those considering alternative approaches to drug regulation is that information on 
any substances that might be made available through controlled outlets would need to stand up 
with respect to truthfulness, accuracy, balance, and scientific validity. 
The continuing lack of certainty or agreement about what is the problem of drug and alcohol use – 
raised by the distinction between less harmful use of less harmful substances for pleasure versus the 
appearance of dependence or addiction and other health problems in heavy or severe users of more 
dangerous substances – is relevant to the issues raised in the article by Hall and Carter 2011. They 
ask ‘if the problem is addiction then is there a role for pioneering futuristic treatments’?  With what 
some have seen as the return of the brain disease model, there have been calls for more 
experimentation in treatments including the use of deep brain stimulation. Hall and Carter conclude 
that evidence suggests that the very uncertain benefits of deep brain stimulation in alleviating the 
symptoms of addiction do not outweigh the known harms associated with the procedure.  
The Royal College of Psychiatrists 2011 report Our Invisible Addicts looked at the neglected issue of 
substance misuse by older people. They argue that this is now a growing public health problem. The 
proportion of older people in the population is increasing rapidly, as is the number of older people 
with substance use problems. Older people may show complex patterns and combinations of 
substance use (e.g. alcohol plus inappropriate use of prescribed medications).  While the young may 
use substances for pleasure, the old seem more likely to use them for relief from pain. A related 
question is what will happen to cohorts of drug-using populations as they get older?  
 
Conclusion 
A number of simple conclusions emerge from our reading: that use of mind and body altering 
substances is ubiquitous and seems to be a feature of all human societies; that the range of 
substances available is wide and increasing; that current controls do not seem to be sufficiently 
effective or appropriate; and that with globalisation many of the problems found in high income 
countries are spreading to low and middle income countries (cf Coomber 1998; Andreas and 
Nadelmann 2006).  Our responses are however complicated and agreement is absent. Many 
interventions by psychiatrists, psychologists, social workers, educationalists and police can be shown 
to be effective and have value. Other policies and practices (often those most favoured) are less 
effective and have unintended consequences.  Our responses can be improved by engaging in calm 
deliberations, informed by the best evidence and respect for the understandings built up over many 
years through the research, scholarship and experience of those who have committed time and 
effort to drug and alcohol studies. It is hoped that the articles collected in these six volumes, 
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together with further reading, will help to support much needed improvements in understanding 
and in policy. 
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